002252 Shanghai RAAS Blood Products
- 7.19
- +0.01+0.14%
Shanghai RAAS Blood Products News
Shanghai Rice: 2024 Semi-Annual Equity Distribution Implementation Notice
Shanghai Rice: Announcement on the 2024 Mid-Term Profit Distribution Plan
Shanghai RAAS Blood Products: Announcement of Completion of Remaining Stock Repurchase Cancellation and Share Changes
Shanghai RAAS Blood Products: Notice on the pledge of shares by shareholders holding more than 5% of the shares
Shanghai RAAS Blood Products: Announcement regarding the progress and completion of transfer and registration of the company's share transfer agreement.
Shanghai RAAS Blood Products: Announcement on the completion of the plan to increase the shareholding of some directors, supervisors and all senior management of the company
Shanghai RAAS Blood Products: 2023 Annual Equity Distribution Implementation Notice
Shanghai RAAS Blood Products: Special inspection opinion of Shenwan Hongyuan Securities Underwriting and Sponsorship Co., Ltd. on the fulfillment of performance commitments made by Shanghai Laishi Blood Products Co., Ltd. in issuing shares to purchase assets and related transactions
Shanghai RAAS Blood Products: Notice on the progress of the transfer of the company's shares by agreement with the company's shareholders
Shanghai RAAS Blood Products: Notice on the progress of the transfer of the company's shares by agreement with the company's shareholders
Shanghai RAAS Blood Products: Announcement on the 2023 Profit Distribution Plan
Shanghai Laishi: Announcement on the progress of the company's shareholders' agreement to transfer the company's shares
Shanghai Laishi: Announcement on the plan to increase the shareholding of the company\'s directors, supervisors and all senior management
Shanghai Laishi: Announcement on the progress of the company\'s shareholders\' agreement to transfer the company\'s shares
Shanghai Laishi: An indicative announcement on changes in shareholders\' rights and proposed changes in control of the company
Shanghai Laishi: Shanghai Laishi Blood Products Co., Ltd. Detailed Equity Change Report
Shanghai Laishi: Shanghai Laishi Blood Products Co., Ltd. Simplified Equity Change Report
Shanghai Laishi: Announcement on the completion of cancellation of share repurchases and share changes
Shanghai Laishi: Announcement on the progress of the acquisition of 95% of the shares of Guangxi Guanfeng Biological Products Co., Ltd.
Shanghai Laishi: Announcement on the acquisition of shares in Guangxi Guanfeng Biological Products Co., Ltd. and the signing of the “Share Acquisition Agreement”
Analysis
Price Target
No Data
No Data